![[-]](https://fuerteventura.click/images/collapse.png "[-]")
11-10-2023, 11:29 PM
Radio Sintonia:
Flu and COVID-19 vaccination campaign begins on 16 October.
The Minister of Health of the Government of the Canary Islands, Esther Monzón, presented this morning the vaccination campaign against influenza and COVID-19 for the 2023-24 season, which will begin in all health centers of the archipelago next Monday, October 16, and which incorporates substantial novelties with respect to previous campaigns.
Together with the counselor, the general director of Public Health of the Canary Islands Health Service (SCS), José Díaz-Flores, and the head of the Epidemiology service, Amós García, have detailed the planned operation, the different types of vaccines that will be available to face this season and the advertising campaign that will remember who should be vaccinated.
The Canary Islands have acquired a total of 2023,24 doses of vaccine to face this 335-000 flu season, with a total investment of 2,989,000 euros.
Esther Monzón pointed out that "this year we continue in the situation of coexistence of COVID-19 with other seasonal pathologies such as influenza, so it continues to be essential to vaccinate the most vulnerable groups and essential professionals for the community".
In addition, he recalled that "by vaccinating the at-risk population against influenza, we also avoid the coexistence of the two infections, influenza and COVID-19, in the same person, minimizing the severity of the disease in the patient and the stress to the health system".
For his part, José Díaz-Flores, explained that the information campaign that will be disseminated in digital media, social networks, shift screens in hospitals and health centers, LED screens in the urban environment and radio stations, to remember which are the population groups that are at risk of suffering complications in case of contracting flu or COVID-19, and that they should be vaccinated.
In this sense, the Director General of Public Health insisted that the vaccine is the most effective means to avoid contracting or transmitting the flu, especially in those people who are at risk of suffering complications in case of suffering from the disease and in personnel who are essential for the community such as health and caregivers of the elderly or dependents.
In addition, the head of the Epidemiology service, Amós García, reported that to face this season there will be four types of vaccines aimed at:
Target population older than 6 months. 100,000 doses have been acquired, which has meant an investment of 390,000 euros.
Target population older than 24 months. 180,000 doses have been purchased with a total amount of 1,386,000 euros.
institutionalized elderly population and bedridden elderly at home; over 60 years old. 30,000 doses have been acquired, which has meant an investment of 750,000 euros.
children between two and five years of age (59 months) without underlying pathologies. It can also be used in patients between five and fourteen years of age, including, with underlying pathology that does not have contraindicated. 25,000 doses have been acquired for which 463,000 euros have been invested.
Seasonal Vaccination Recommendations 2023-2024
Each year, autumn-winter flu vaccination recommendations are established for those population groups at higher risk of complications if infected, and for people who may transmit the disease to others who are at high risk of complications. Since the 2021-2022 season, flu vaccination has coincided with COVID-19 vaccination.
The objective of vaccination against the Coronavirus is to strengthen the protection of the most vulnerable people and that of health and socio-health personnel to reduce morbidity and mortality from the SARS-CoV-2 virus and the impact of this disease on the capacity of health and socio-health care.
Flu / COVID-19 vaccination
Taking into account the current epidemiological situation of COVID-19, vaccination during the autumn-winter season (2023-2024) is recommended for the following population groups:
Due to the increased risk of complications or serious conditions in case of suffering from these infections:
People 60 years of age or older.
Persons aged five years or older, inmates in care centres for persons with disabilities and residences for the elderly, as well as other persons institutionalized on a long-term basis and residents in closed institutions.
People under 60 with chronic illnesses such as:
diabetes mellitus and Cushing's syndrome.
morbid obesity (body mass index ≥40 in adults, ≥35 in adolescents or ≥3 SD in childhood).
chronic cardiovascular, neurological or respiratory diseases, including bronchopulmonary dysplasia, cystic fibrosis and asthma.
chronic kidney disease and nephrotic syndrome.
haemoglobinopathies and anaemias or haemophilia, other coagulation disorders and chronic bleeding disorders, as well as recipients of blood products and multiple transfusions.
Asplenia or severe splenic dysfunction.
chronic liver disease, including chronic alcoholism.
Serious neuromuscular diseases.
immunosuppression.
cancer and malignant blood diseases.
Cerebrospinal fluid fistula and or awaiting cochlear implant.
celiac disease.
chronic inflammatory disease.
disorders and diseases that lead to cognitive dysfunction: Down syndrome, dementia and others.
Pregnant women in any trimester of gestation and women during the puerperium (up to six months after delivery).
Cohabitants with people with a high degree of immunosuppression, with people with other diseases at higher risk and with older people.
To reduce the impact and maintenance of critical and essential services to the community:
Staff of health centres and establishments (including pharmacies) and public and private social and health centres (both health and non-health personnel).
People working in essential public services, with special emphasis on the following subgroups:
National, regional and local security forces and bodies.
Armed forces.
Civil Protection Services.
Flu vaccination
In addition to the above groups, influenza vaccination is also recommended for:
Child population between six and 59 months (5 years) of age.
People aged five to 59 years with an increased risk of complications from the flu, such as those between the ages of five and 18 who are on long-term aspirin therapy, or all smokers.
Students in internships in health centers and establishments (including pharmacies) and social health.
People with direct occupational exposure to animals or their secretions in poultry, pig or mink farms or wildlife (birds, wild boars or mustelids), such as farmers, veterinarians, farm workers, hunters, ornithologists, environmental agents, Zoo personnel, etc. The purpose of vaccination of these groups is to reduce the opportunity for concomitant infection of human and avian or porcine viruses, reducing the possibility of recombination or genetic exchange between both viruses.
Flu and COVID-19 vaccination campaign begins on 16 October.
The Minister of Health of the Government of the Canary Islands, Esther Monzón, presented this morning the vaccination campaign against influenza and COVID-19 for the 2023-24 season, which will begin in all health centers of the archipelago next Monday, October 16, and which incorporates substantial novelties with respect to previous campaigns.
Together with the counselor, the general director of Public Health of the Canary Islands Health Service (SCS), José Díaz-Flores, and the head of the Epidemiology service, Amós García, have detailed the planned operation, the different types of vaccines that will be available to face this season and the advertising campaign that will remember who should be vaccinated.
The Canary Islands have acquired a total of 2023,24 doses of vaccine to face this 335-000 flu season, with a total investment of 2,989,000 euros.
Esther Monzón pointed out that "this year we continue in the situation of coexistence of COVID-19 with other seasonal pathologies such as influenza, so it continues to be essential to vaccinate the most vulnerable groups and essential professionals for the community".
In addition, he recalled that "by vaccinating the at-risk population against influenza, we also avoid the coexistence of the two infections, influenza and COVID-19, in the same person, minimizing the severity of the disease in the patient and the stress to the health system".
For his part, José Díaz-Flores, explained that the information campaign that will be disseminated in digital media, social networks, shift screens in hospitals and health centers, LED screens in the urban environment and radio stations, to remember which are the population groups that are at risk of suffering complications in case of contracting flu or COVID-19, and that they should be vaccinated.
In this sense, the Director General of Public Health insisted that the vaccine is the most effective means to avoid contracting or transmitting the flu, especially in those people who are at risk of suffering complications in case of suffering from the disease and in personnel who are essential for the community such as health and caregivers of the elderly or dependents.
In addition, the head of the Epidemiology service, Amós García, reported that to face this season there will be four types of vaccines aimed at:
Target population older than 6 months. 100,000 doses have been acquired, which has meant an investment of 390,000 euros.
Target population older than 24 months. 180,000 doses have been purchased with a total amount of 1,386,000 euros.
institutionalized elderly population and bedridden elderly at home; over 60 years old. 30,000 doses have been acquired, which has meant an investment of 750,000 euros.
children between two and five years of age (59 months) without underlying pathologies. It can also be used in patients between five and fourteen years of age, including, with underlying pathology that does not have contraindicated. 25,000 doses have been acquired for which 463,000 euros have been invested.
Seasonal Vaccination Recommendations 2023-2024
Each year, autumn-winter flu vaccination recommendations are established for those population groups at higher risk of complications if infected, and for people who may transmit the disease to others who are at high risk of complications. Since the 2021-2022 season, flu vaccination has coincided with COVID-19 vaccination.
The objective of vaccination against the Coronavirus is to strengthen the protection of the most vulnerable people and that of health and socio-health personnel to reduce morbidity and mortality from the SARS-CoV-2 virus and the impact of this disease on the capacity of health and socio-health care.
Flu / COVID-19 vaccination
Taking into account the current epidemiological situation of COVID-19, vaccination during the autumn-winter season (2023-2024) is recommended for the following population groups:
Due to the increased risk of complications or serious conditions in case of suffering from these infections:
People 60 years of age or older.
Persons aged five years or older, inmates in care centres for persons with disabilities and residences for the elderly, as well as other persons institutionalized on a long-term basis and residents in closed institutions.
People under 60 with chronic illnesses such as:
diabetes mellitus and Cushing's syndrome.
morbid obesity (body mass index ≥40 in adults, ≥35 in adolescents or ≥3 SD in childhood).
chronic cardiovascular, neurological or respiratory diseases, including bronchopulmonary dysplasia, cystic fibrosis and asthma.
chronic kidney disease and nephrotic syndrome.
haemoglobinopathies and anaemias or haemophilia, other coagulation disorders and chronic bleeding disorders, as well as recipients of blood products and multiple transfusions.
Asplenia or severe splenic dysfunction.
chronic liver disease, including chronic alcoholism.
Serious neuromuscular diseases.
immunosuppression.
cancer and malignant blood diseases.
Cerebrospinal fluid fistula and or awaiting cochlear implant.
celiac disease.
chronic inflammatory disease.
disorders and diseases that lead to cognitive dysfunction: Down syndrome, dementia and others.
Pregnant women in any trimester of gestation and women during the puerperium (up to six months after delivery).
Cohabitants with people with a high degree of immunosuppression, with people with other diseases at higher risk and with older people.
To reduce the impact and maintenance of critical and essential services to the community:
Staff of health centres and establishments (including pharmacies) and public and private social and health centres (both health and non-health personnel).
People working in essential public services, with special emphasis on the following subgroups:
National, regional and local security forces and bodies.
Armed forces.
Civil Protection Services.
Flu vaccination
In addition to the above groups, influenza vaccination is also recommended for:
Child population between six and 59 months (5 years) of age.
People aged five to 59 years with an increased risk of complications from the flu, such as those between the ages of five and 18 who are on long-term aspirin therapy, or all smokers.
Students in internships in health centers and establishments (including pharmacies) and social health.
People with direct occupational exposure to animals or their secretions in poultry, pig or mink farms or wildlife (birds, wild boars or mustelids), such as farmers, veterinarians, farm workers, hunters, ornithologists, environmental agents, Zoo personnel, etc. The purpose of vaccination of these groups is to reduce the opportunity for concomitant infection of human and avian or porcine viruses, reducing the possibility of recombination or genetic exchange between both viruses.